Literature DB >> 33106308

Zhikang Ye1, Bram Rochwerg1, Ying Wang1, Neill K Adhikari1, Srinivas Murthy1, François Lamontagne1, Robert A Fowler1, Haibo Qiu1, Li Wei1, Ling Sang1, Mark Loeb1, Ning Shen1, Minhua Huang1, Zhaonan Jiang1, Yaseen M Arabi1, Luis Enrique Colunga-Lozano1, Li Jiang1, Younsuck Koh1, Dong Liu1, Fang Liu1, Jason Phua1, Aizong Shen1, Tianyi Huo1, Bin Du2, Suodi Zhai2, Gordon H Guyatt2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33106308      PMCID: PMC7577570          DOI: 10.1503/cmaj.200648-f

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  31 in total

1.  GRADE guidelines 6. Rating the quality of evidence--imprecision.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; Jan Brozek; Pablo Alonso-Coello; David Rind; P J Devereaux; Victor M Montori; Bo Freyschuss; Gunn Vist; Roman Jaeschke; John W Williams; Mohammad Hassan Murad; David Sinclair; Yngve Falck-Ytter; Joerg Meerpohl; Craig Whittington; Kristian Thorlund; Jeff Andrews; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-08-11       Impact factor: 6.437

2.  GRADE guidelines: 9. Rating up the quality of evidence.

Authors:  Gordon H Guyatt; Andrew D Oxman; Shahnaz Sultan; Paul Glasziou; Elie A Akl; Pablo Alonso-Coello; David Atkins; Regina Kunz; Jan Brozek; Victor Montori; Roman Jaeschke; David Rind; Philipp Dahm; Joerg Meerpohl; Gunn Vist; Elise Berliner; Susan Norris; Yngve Falck-Ytter; M Hassan Murad; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-30       Impact factor: 6.437

3.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency.

Authors:  Gordon H Guyatt; Andrew D Oxman; Regina Kunz; James Woodcock; Jan Brozek; Mark Helfand; Pablo Alonso-Coello; Paul Glasziou; Roman Jaeschke; Elie A Akl; Susan Norris; Gunn Vist; Philipp Dahm; Vijay K Shukla; Julian Higgins; Yngve Falck-Ytter; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2011-07-31       Impact factor: 6.437

4.  Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.

Authors:  Qingxian Cai; Minghui Yang; Dongjing Liu; Jun Chen; Dan Shu; Junxia Xia; Xuejiao Liao; Yuanbo Gu; Qiue Cai; Yang Yang; Chenguang Shen; Xiaohe Li; Ling Peng; Deliang Huang; Jing Zhang; Shurong Zhang; Fuxiang Wang; Jiaye Liu; Li Chen; Shuyan Chen; Zhaoqin Wang; Zheng Zhang; Ruiyuan Cao; Wu Zhong; Yingxia Liu; Lei Liu
Journal:  Engineering (Beijing)       Date:  2020-03-18       Impact factor: 7.553

5.  [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19].

Authors:  Jun Chen; Danping Liu; Li Liu; Ping Liu; Qingnian Xu; Lu Xia; Yun Ling; Dan Huang; Shuli Song; Dandan Zhang; Zhiping Qian; Tao Li; Yinzhong Shen; Hongzhou Lu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

6.  Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.

Authors:  Y O Y Soo; Y Cheng; R Wong; D S Hui; C K Lee; K K S Tsang; M H L Ng; P Chan; G Cheng; J J Y Sung
Journal:  Clin Microbiol Infect       Date:  2004-07       Impact factor: 8.067

7.  Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.

Authors:  Xiaochen Li; Shuyun Xu; Muqing Yu; Ke Wang; Yu Tao; Ying Zhou; Jing Shi; Min Zhou; Bo Wu; Zhenyu Yang; Cong Zhang; Junqing Yue; Zhiguo Zhang; Harald Renz; Xiansheng Liu; Jungang Xie; Min Xie; Jianping Zhao
Journal:  J Allergy Clin Immunol       Date:  2020-04-12       Impact factor: 10.793

8.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

9.  Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.

Authors:  Hoe-Nam Leong; Brenda Ang; Arul Earnest; Cindy Teoh; Wei Xu; Yee-Sin Leo
Journal:  Trop Med Int Health       Date:  2004-08       Impact factor: 2.622

10.  Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.

Authors:  Joseph Magagnoli; Siddharth Narendran; Felipe Pereira; Tammy H Cummings; James W Hardin; S Scott Sutton; Jayakrishna Ambati
Journal:  Med (N Y)       Date:  2020-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.